Mesothelioma Hub Blog

The European Thoracic Oncology Platform (ETOP) recently completed a disappointing phase 3 trial for mesothelioma treatment.

Phase II of a clinical trial is recruiting mesothelioma patients to test the effectiveness of two immunotherapy medications in combination.

Each year on September 26th, the medical community observes Mesothelioma Awareness Day. This year, Mesothelioma Hub remembers Inez St. John.

Making Immunotherapy Mainstream An immunotherapy procedure showing promise in the treatment of mesothelioma may soon be covered under Medicare. In August, the Centers for Medicare & Medicaid Services (CMS) approved the use of Chimeric Antigen Receptor, (CAR T-cell), therapy in patients with two specific cancers: non-Hodgkin lymphoma and B-cell precursor acute lymphoblastic leukemia.  CAR T-cell … Continued

The results of a recent Phase 3 clinical trial have led to a disappointing setback for the mesothelioma community: a highly-touted immunotherapy drug has failed to stop the progression of the disease. Researchers involved in the LUME-Meso study, which combined Ofev (nintedanib) with first-line chemotherapy drugs, say the treatment failed to slow the progression of … Continued

Emergency responders, health care professionals, and recovery workers injured on September 11th now have medical compensation for the next 70 years. President Donald Trump signed the 9/11 Victim Compensation Fund (VCF) bill into law during a ceremony on Monday at the White House Rose Garden. Members of the Senate approved the bill just last week. … Continued

Americans use personal care products, from deodorant to lotions to makeup, every day. We don’t always know what’s in these products and often place our trust in the companies that manufacture them. Unfortunately, these corporations don’t always have the consumer’s best interest in mind. Case-in-point: traces of asbestos, a toxic, microscopic fiber that’s unsafe at … Continued

The latest treatment for mesothelioma patients combines the power of electric currents with platinum-based chemotherapy drugs. New Technology Disrupts Cancer Cell Division Patients have a new weapon in the fight against pleural mesothelioma: Novocure’s TTF-100L™ System. Last month, the Food and Drug Administration (FDA) approved the global oncology company’s “Tumor Treating Fields” (TTF) technology for … Continued

It’s not always something people consider when taking a daily prescription or over-the-counter pain reliever, but many medications used in the medical field today are derived from plants. For patients, this raises an important question: can herbal medicine help the body fight cancers like mesothelioma? Botanicals and Cancer Treatment Patients who receive a mesothelioma diagnosis … Continued

An new Phase 1 clinical trial using chimeric antigen receptor (CAR) T-cell therapy to attack pleural mesothelioma tumors shows promise for cancer patients.